We report the synthesis and labeling with iodine-123 of N-(piperidin-1-yl)-5-(4-iodophenyl)-l-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (AM251). This compound is an analog of the recently described cannabinoid receptor antagonist, SR1417164 in which a 4-chlorophenyl group is replaced b
Iodine-123 labeled derivatives of methylphenidate: Potential SPECT radiopharmaceuticals for brain dopamine transporters
β Scribed by D. Pan; S. J. Gatley; R. Chen; Y.-S. Ding
- Book ID
- 101289875
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- French
- Weight
- 479 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
β¦ Synopsis
Since d-threo-[ "C]methylphenidate (Ritalin) and especially the more active enantiomer, drhreo-["C]methylphenidate, have favorable properties for PET studies,we prepared two radioiodinated analogs of methylphenidate, p-['UI]iodomethylphenidate and m-[ '231Jiod0p-hydroxymethylphenidate with a view to evaluating them as potential SPECT tracers. To prepare p-['UI]iodomethylphenidate, the p-tributyltin derivative was prepared from the previously reported p-bromomethylphenidate and reacted under acidic conditions w i t h I-123 iodide plus chloramine-T at room temperature for 90 seconds. The predominant radioactive product was obtained in 85% radiochemical yield and >10 CVpmol specific radioactivity after HPLC purification. It had the same HPLC retention time as a spectroscopically characterized non-radioactive p-iodomethylphenidate standard prepared via nitration of methylphenidate and diazotization, after protection of the secondary amino group by benzoylation. A second radioicdinated methylphenidate derivative, m-[l"I]iodop-hydroxymethylphenidate was prepared in 80% radiochemical yield by direct iodination of the known p-hydroxymethylphenidate. In this case the non-radioactive standard was prepared by iodination of p-hydroxyritalinic acid using 12 and iodic acid, followed by esterifkation.
π SIMILAR VOLUMES
## Abstract [^123^I]1β[2β(Diphenylmethoxy)ethyl]β4β[3β(__m__βiodophenyl)β2βpropenyl]piperazine ([^123^I]2), a potential SPECT imaging agent for dopamine reuptake sites was efficiently synthesized in 4 steps from 1β[2β(diphenylmethoxy)ethyl]piperazine (3). A key step in the synthesis was the selecti